Full Text View
Tabular View
No Study Results Posted
Related Studies
Colistin and Rifampicin for MDR-Acinetobacter (CoRAb)
This study has been completed.
Study NCT01577862   Information provided by Second University of Naples

First Received on April 10, 2012.   Last Updated on April 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infection Due to Resistant Bacteria
Pneumonia, Ventilator-Associated
Hospital Acquired Pneumonia
Infection of Bloodstream
Infectious Disease of Abdomen
Additional conditions recognized in this trial
Communicable Diseases
Infection
Pneumonia
More general conditions related to this trial
Cross Infection
Lung Diseases
Lung Injury
Respiratory Tract Diseases
Respiratory Tract Infections
Ventilator-Induced Lung Injury
Interventions listed in this trial
Colistin
Rifampicin
Additional drug interventions recognized in this trial
Rifampin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Antitubercular Agents
Enzyme Inhibitors
Leprostatic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Second University of Naples
Federico II University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services